Exclusive Ticket Pricing EXTENDED through September 30
Why South Africa?
We’ll be lighting up Cape Town with the brightest minds and most illuminating content in medical cannabis this November 2019!
South Africa legalised the production and export of medical cannabis in 2017 and is expected to become a global frontrunner in the industry. The South African Supreme Court’s legalisation of cannabis for personal recreational use further propelled the country’s entry into the market. With estimates that the cannabis and associated products market could be worth R27 billion by 2023, this immense potential has led to a boom in regional cannabis license application and investment.
With inexpensive land and labour force, and an ideal climate for cannabis cultivation, Africa is in the midst of a green rush. The Kingdom of Lesotho, a sovereign nation of 2 million bordered on all sides by South Africa, granted the continent’s first license to grow and export legal medical cannabis in 2017. Currently, a number of African countries, including Swaziland, Malawi, and Zimbabwe, are examining legalizing cannabis cultivation for medical or industrial applications.
The global interest in Africa’s cannabis market and South Africa’s recent legislative acceptance of cannabis makes Cape Town the perfect destination for CannaTech. Showcasing leading-edge R&D, industry mavens, and thought leaders, CannaTech is a premier event contributing to the growth of the medical cannabis ecosystem. Don’t miss out on your chance to join global cannabis influencers in propelling innovation – sponsorship opportunities are currently available.
JOIN US IN CAPE TOWN, SOUTH AFRICA
Exclusive Ticket Pricing through September 30
CAPE TOWN AGENDA
Apply here to pitch your cannabis business concept live at CannaTech and for the chance to win an exclusive iCan prize package. Hundreds of high net worth investors seeking opportunities in the cannabis industry.
Apply here for special access to the CannaTech Deal Room. This unique opportunity to connect with a vetted cohort of high market potential companies is only open to qualified investors with demonstrated experience.